Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of recombinant human TSH in T-cell development in adults with treated primary hypothyroidism
NL-OMON33266Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of thyrotropin alfa in immunocompromise and T-cell developmental disorder, sponsored by Erasmus MC. Primary endpoints: Change in thymic output, Change in peripheral cell numbers and 1 more. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
immunocompromiseT-cell developmental disorder
Beyond the preview
Go deeper on NL-OMON33266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33266.